English |Pусский |Português |Pусский |عربي

19. Effects of kanglaite capsules combined with transcatheter arterial chemoembolization (TACE) on patients with mid or late-stage primary hepatocellular carcinoma (HCC)

(Summary description)

19. Effects of kanglaite capsules combined with transcatheter arterial chemoembolization (TACE) on patients with mid or late-stage primary hepatocellular carcinoma (HCC)

(Summary description)

img

Copyright © 2012 ZHEJIANG KANGLAITE GROUP CO. LTD. All Rights Reserved | Powered by: Ce300.cn | 浙ICP备05054550号-1 | [Manage]